Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase NA 2Phase 2 1

Status

Recruiting 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3

Conditions

Breast Neoplasms 3Vomiting 2Nausea 2Sleep Initiation and Maintenance Disorders 1Pancreatic Neoplasms 1Pain 1Neoplasms 1

Interventions

Cyclophosphamide 149Docetaxel 139Paclitaxel 127Trastuzumab 120Tamoxifen 110Capecitabine 104Letrozole 92Epirubicin 79Doxorubicin 70Anastrozole 70exemestane 67Fulvestrant 65Fluorouracil 61Radiotherapy 60pertuzumab 40Gemcitabine 39Carboplatin 38Vinorelbine 34Goserelin 34Bevacizumab 29Zoledronic Acid 28Methotrexate 28Chemotherapy, Adjuvant 28eribulin 27Lapatinib 25ribociclib 24palbociclib 24Drug Therapy 22130-nm albumin-bound paclitaxel 20pegfilgrastim 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Breast Neoplasms × Electroacupuncture × Clear all
NCT06952920 2025-12-15

Electroacupuncture for Chemotherapy-Induced GI Symptom Clusters in Breast Cancer

Affiliated Hospital of Qinghai University

Phase 3 Recruiting
388 enrolled
Breast

Breast Neoplasms

NCT06200168 2025-04-02

Electroacupuncture for the Prevention of Chemotherapy-induced Nausea and Vomiting in Patients With Breast Cancer

Affiliated Hospital of Qinghai University

Phase 3 Recruiting
370 enrolled
Breast

Breast Neoplasms, Nausea, Vomiting

NCT06314906 2024-03-21

Electroacupuncture Plus Antiemetic Therapy for Chemotherapy-Induced Nausea and Vomiting in Patients With Breast Cancer

Lanzhou University Second Hospital

Phase 3 Recruiting
370 enrolled
Breast

Breast Neoplasms, Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡